Advisory Board February 24, 2023
Apple may be able to bring noninvasive and continuous blood glucose monitoring technology to market after the secret project — which has been in the works for over a decade — hit some major milestones, Mark Gurman reports for Bloomberg.
Inside Apple’s secret project
The project, known as E5, began in 2010 after Apple co-founder Steve Jobs directed the company to purchase RareLight, which touted a new approach to noninvasive blood glucose monitoring.
The goal of the project is to measure the amount of glucose in someone’s body without having to prick their skin for blood. To do this, Apple uses a chip technology called silicon photonics alongside a measurement process called optical absorption spectroscopy.
According to people familiar with...
Today's Sponsors
Today's Sponsor